Pitch Introduction
The WeHear Shark Tank India pitch began with a powerful ten-second silence, highlighting the daily reality for millions suffering from hearing loss. Founders Kanishka Patel and Raj Shah brought a revolutionary medical technology to the tank, aiming to solve a problem that affects over 25 million people globally who cannot hear and find conventional hearing aids ineffective.
As per WHO estimates, by 2030, nearly one in eight people—approximately 1 billion individuals—will experience some form of hearing loss. While the current solution for many is a surgery costing around ₹8 Lakhs, WeHear offers a patented, non-surgical alternative at a fraction of the cost, making hearing healthcare accessible to the masses.
Business Overview
Founded in 2017 and based in Ahmedabad, Gujarat, WeHear is a deep-tech medical company focused on cost-effective hearing solutions. Unlike traditional hearing aids that amplify sound through the ear canal, WeHear uses Bone Conduction Technology. This tech bypasses the physical ear and delivers sound vibrations directly to the brain through the skull.
The company operates in both the B2B and B2C segments. Their flagship product, HearNU, targets individuals with severe hearing impairments, while their Hear.O line provides health-friendly smart headphones for the general public to prevent future hearing damage. With a dedicated team of 38 developers and 3 granted patents, WeHear is positioning itself as a leader in the global audiology market.
Product Details
The HearNU device is a non-surgical solution for people with Microtia or other physical ear defects. It consists of a band containing multiple 360-degree microphones and a microprocessor that tunes audio specifically for each ear. This processed sound is then transmitted via transducers placed on the temporal bone, sending vibrations directly to the cochlea.
Their secondary product, Hear.O, is a smart headphone designed for open-ear listening. It features dual connectivity support, 16-channel programmability, and indoor/outdoor modes. These headphones are specifically marketed to reduce the ear infections and damage caused by prolonged use of traditional in-ear buds.
Market Position
WeHear occupies a unique niche between the high-cost surgical implant market and the mass-market hearing aid industry. While a cochlear implant surgery can cost upwards of ₹8 Lakhs, WeHear’s solution is priced at approximately ₹80,000, offering a 90% cost reduction for patients. Their target market includes 25 million people globally who currently have no option other than surgery.
| Business Detail | Information |
|---|---|
| Company Name | WeHear Innovations |
| Founders | Kanishka Patel & Raj Shah |
| Product Type | Bone Conduction Hearing Aids |
| Price Range | ₹35,000 to ₹80,000 |
| Primary Channel | B2B (Stockists) & Exports |
| Headquarters | Ahmedabad, Gujarat |
About Founder’s
The visionaries behind WeHear, Kanishka Patel and Raj Shah, are alumni of Narsee Monjee Institute of Management Studies (NMIMS). According to YourStory, the founders started the company with a focus on deep tech and R&D, aiming to make India a hub for hearing aid manufacturing, a market currently dominated by expensive imports from brands like Siemens.
- Kanishka Patel: Lead product visionary and CEO with a background in engineering.
- Raj Shah: Strategic lead focused on global expansion and investor relations.
- The duo secured their first angel round in 2021 from a batchmate at NMIMS.
- They have successfully secured grants and recognition from the National Institute of Speech and Hearing.
Shark’s and Founder’s QnA
What is the difference between normal bone conduction headphones and your device?
Normal bone conduction headphones are like sunglasses; anyone can wear them. Our device is a hearing care device, similar to spectacles. It is configured specifically to the user’s ears, processing sound through a microprocessor before sending it to the cochlea.
Which segment of the market are you currently focusing on?
Our first focus is the surgical solution, which currently accounts for 70% of our revenue. The remaining 30% comes from our consumer wearable smart headphones. We are also preparing to launch a conventional inner-ear hearing aid to compete with imports.
You have 3 patents, but why do you only have 50 Lakhs in the bank if you’ve raised so much?
We just closed a round for ₹8 Crores investment at a ₹268 Crores post-money valuation. That money is committed and expected in our bank within the next six days. Most of our previous capital went into R&D and setting up our 38-person technical team.
Why are you looking for investors in Dubai and France rather than India?
Initially, when we approached Indian VCs, they felt our revenue didn’t justify our valuation or that the technology wasn’t proven. So, we went to people who believed in the tech, including ENT surgeons in Dubai who invited us after seeing our results.
How do you distribute your products in India?
We use a stockist model. We have appointed stockists in 11 cities. Once we grant them a territory, they sell to local clinics and hospitals. We have already sold 1,200 devices through this network, with significant reorders from four major stockists.
What is your vision for the next five years?
I see this as a one billion dollar company. In FY 2024-25, we aim to be in 30 Indian cities and 25 countries globally. Our top-line target for the near future is ₹160 Crores with a goal of selling one lakh devices.
Key Stats & Financials
WeHear demonstrated impressive growth metrics, jumping from a ₹5 Crore valuation in 2021 to a massive ₹268 Crore valuation by late 2023. Their financial performance shows a clear upward trajectory, particularly in the months leading up to their appearance on Shark Tank.
Revenue and Profitability
- FY 2023-24 Revenue (till Sept): ₹2.82 Crores
- Monthly Sales (Sept 2023): ₹93 Lakhs
- Monthly Sales (Aug 2023): ₹89 Lakhs
- Entrepreneur Valuation: ₹250 Crores
- Total Lifetime Sales: Over ₹5 Crores
Financial Breakdown
| Metric | Amount / Value |
|---|---|
| Yearly Revenue (Pitch Year) | ₹2.82 Crores | ₹93 Lakhs |
| August Monthly Sales | ₹89 Lakhs |
| July Monthly Sales | ₹14.25 Lakhs |
| Current Cash in Bank | ₹50 Lakhs |
| Ask Valuation | ₹250 Crores |
Business Potential and TAM
The global hearing aid market is a massive sector, valued at approximately $11.1 Billion in 2023, and it is expected to grow at a CAGR of over 5% through 2030. In India, the market is heavily reliant on imports, with goods worth ₹5,000 Crores entering the country annually. WeHear’s potential lies in its ability to offer “Make in India” solutions that are significantly more affordable than international competitors.
Market Size Analysis
The Total Addressable Market (TAM) for WeHear includes the 1 billion people worldwide suffering from hearing loss. Specifically, they target the 25 million individuals with profound hearing loss who are candidates for surgery. In India alone, there is a gap of millions who need hearing assistance but cannot afford the ₹65,000 to ₹8 Lakh price tags associated with premium aids and implants.
Growth Opportunities
- Export Expansion: Scaling presence in Dubai, Kenya, and the broader GCC and African markets.
- Conventional Hearing Aid Launch: Disrupting the ₹5,000 Crore import market with ₹35,000 locally made pairs.
- Tinnitus Solutions: Launching specialized devices for the growing population suffering from ear noise issues.
- Government Partnerships: Leveraging testing results from the National Institute of Speech and Hearing for public health tenders.
WeHear: Ideal Target Audience & Demographics
| Demographic | Details |
|---|---|
| Primary Age Group | 45 to 80 Years (Hearing Aid Users) |
| Secondary Age Group | 5 to 18 Years (Children with Birth Defects) |
| Consumer Tech Segment | 18 to 40 Years (Hear.O Headphone Users) |
| Platform Preference | Medical Journals, Health Expos, LinkedIn |
| Geography | Tier 1 & Tier 2 Indian Cities, UAE, Kenya |
| Buying Behavior | Consultation-led, High-Trust medical purchases |
Marketing and Distribution Strategy
WeHear utilizes a dual distribution strategy. For their medical devices, they rely on a robust B2B network of medical stockists who interface with ENT specialists and audiologists. For their consumer range, they leverage digital platforms and global trade shows to build brand awareness.
Customer Acquisition
Acquisition is primarily driven through clinical recommendations. By presenting their patented tech to surgeons and audiologists, they gain high-intent referrals. This professional validation is their strongest marketing tool, significantly lowering the Customer Acquisition Cost (CAC) compared to traditional retail advertising.
Distribution Channels
- City-wise Stockists: Currently active in 11 cities with a roadmap for 30 cities.
- Direct Exports: Major shipments already sent to Kenya and Dubai.
- Online D2C: Selling Hear.O smart headphones through their official website.
- Medical Institutions: Strategic partnerships with institutes like Ali Yavar Jung National Institute of Speech and Hearing.
Social Media and Content Strategy
The company focuses on educational content, highlighting the dangers of traditional earphones and the benefits of bone conduction. Their social media channels feature testimonials from children and adults whose lives were changed by the HearNU device, creating an emotional and clinical impact.
WeHear Shark Tank Deal Outcome
The pitch saw intense debate regarding the ₹250 Crores valuation. Anupam Mittal expressed skepticism about the rapid valuation jump and the tech’s uniqueness, eventually opting out. However, Peyush Bansal was impressed by the technology and the mission to solve such a profound human problem.
| Shark | Offer Detail |
|---|---|
| Peyush Bansal | ₹1 Crore for 1% Equity + ₹1.5 Crore Debt @ 9% (Initial) |
| Anupam Mittal | Out – Skeptical of Valuation and IP |
| Namita Thapar | Out – Valuation too high for current returns |
| Vineeta Singh | Out – Scaling complexity |
| Final Decision | ₹2.5 Crores for 1% Equity + 1.5% Advisory Equity |
WeHear Post-Show Update
According to The Indian Express, the deal with Peyush Bansal was one of the most significant tech investments of the season. Post-show, WeHear has continued its expansion into international markets. The company has since gained further accolades for its Make in India success story, helping thousands of children under various government initiatives in Gujarat.
Business Analysis & Lessons
The WeHear pitch was a classic case of IP-led valuation. While their revenue was ₹2.82 Crores, their valuation of ₹250 Crores was based on the defensibility of their patents and the massive size of the untapped global market. This created a divide among the sharks: some saw a risky pre-revenue-style valuation, while Peyush Bansal saw a generational technology company.
For entrepreneurs, WeHear teaches the importance of Global Benchmarking. By looking at international surgery costs and import prices, the founders were able to justify a high price point for their device while still remaining the most affordable option for the consumer. Their focus on R&D over immediate marketing spend built a moat that eventually attracted high-tier investment.
Key Takeaways
- Lesson 1: Patent Protection: Having 3 granted patents allowed the founders to stand firm on a ₹250 Crore valuation despite relatively low revenue.
- Lesson 2: Diversified Revenue: Balancing 70% medical and 30% consumer sales provides both stability and high-growth potential.
- Lesson 3: Credibility via Testing: Validation from the National Institute of Speech and Hearing was crucial in convincing skeptical investors.
- Lesson 4: Disruptive Pricing: Offering a ₹80,000 solution against a ₹8 Lakh surgery is a powerful value proposition that drives its own demand.
Pitch Conclusion
WeHear stands as a prime example of Indian innovation tackling global healthcare challenges. By securing ₹2.5 Crores from Peyush Bansal, the company is well-positioned to scale its patented bone conduction technology across the world. If you enjoyed this breakdown, check out DigiQure, CureSee, and MeduLance.
[faq_accordian]